Apple Tree Partners

Apple Tree Partners (ATP) is a life sciences venture capital firm founded in 1999 that builds and invests in science-based companies across the biotechnology, pharmaceutical research and development, and broader research-driven business sectors. The firm's stated investment range runs from seed stage through IPO and beyond, distinguishing it from funds concentrated on a single financing window. It operates from offices in New York, Boston and London.

ATP's activities extend beyond capital provision into company creation. The firm collaborates with scientists on pre-intellectual property ideas - that is, before patent protection has been secured - and forms spinouts from the pipelines of existing companies. This venture-building function sits alongside conventional portfolio investing and reflects a hands-on, long-term partnership approach with the management teams it backs, including work on strategic transactions and synergistic business combinations.

Strategic and operational support is the third pillar of the model: the firm provides strategic insight and operational resources to portfolio companies rather than acting solely as a financial investor. The combination of early-stage scientific engagement, stage-spanning capital and transaction support is characteristic of a small group of life sciences investors that construct companies as well as finance them - a segment where capability across scientific diligence, corporate development and capital markets is required of the investment team.